skip to main content
Computational Biology Lab
University of Mississippi

Peer Reviewed Original Contribution

    1. Renert-Yuval Y*, Pavel AB*,  Bose S, Gomez-Arias P, Rangel S, Estrada Y, Paller A, Guttman E. Tapestrips capture atopic dermatitis-related changes in non-lesional skin throughout maturation. Allergy. In press. *equal contribution.
    2. Pavel AB*, Glickman JW, Michels JR, Kim-Schultze S, Miller RL, Guttman-Yassky E. Th2/Th1 cytokine imbalance is associated with higher COVID-19 risk mortality. Frontiers in Genetics. 2021. *corresponding author.
    3. Ungar B, Glickman JW, Golant A, Dubin C, Marushchak O, Gontzes A, Mikhaylov D, Singer G, Baum D, Wei N, Sanin A, Gruenstein D, Lebwohl M, Pavel AB, Guttman-Yasssky E. COVID-19 symptoms are attenuated in moderate-to-severe atopic dermatitis patients treated with dupilumab. Journal of Allergy and Clinical Immunology: In Practice. 2022.
    4. Michels JR, Nazrul MS, Adhikari S, Wilkins D, Pavel AB*. *corresponding author. Th1, Th2 and Th17 inflammatory pathways synergistically predict cardiometabolic protein expression in serum of COVID-19 patients. Molecular Omics. 2022.
    5. Ungar B, Lavin L, Golant A, Gontzes A, David E, Estrada Y, Singer G, Pavel AB, Guttman-Yassky E. The impact of Dupilumab treatment on SARS-CoV2/COVID-19 antibody responses in atopic dermatitis patients. Annals of Allergy, Asthma & Immunology. 2022.
    6. Renert-Yuval Y, Correa Da Rosa J, Garcet S, Pavel AB, Bares J, Chima M, Howkes JE, Gilleaudeau P, Sullivan-Whalen MSinger GK , Krueger JGGuttman-Yassky E.  Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes. The British Journal of Dermatology. doi: 10.1111/bjd.21696.
    7. Lefferdink R, Rangel S, Chima M, Ibler E, Pavel AB, Kim H, Wu B, Abu-Zayed H, Jackson K, Singer G, Choate K, Guttman-Yassky E, Paller A. Secukinumab responses vary across the spectrum of congenital ichthyosis in adults. Archives in Dermatological Research. 2022.
    8. Kim M, Mikhaylov D, Rangel S, Pavel AB, He H, Renert-Yuval Y, Del Duca E, Kunal M, Huynh Thy, Sun M, Zhang N, Estrada Y, Paller A, Guttman-Yassky E. Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier Signatures. Journal of Investigative Dermatology. 2022.
    9. Guttman-Yassky E, Pavel AB, Diaz A, Zhang N, Del Duca E, Estrada Y, King B, Banerjee A, Banfield C, Cox LA, Dowty ME, Page K, Vincent MS, Zhang W, Zhu L, Peeva E. Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers. Journal of Allergy and Clinical Immunology. 2021.
    10. Badi YE, Pavel AB, Pavlidis S, Riley JH, Bates S et al. Mapping atopic dermatitis and anti-IL-22 response signatures to Type 2-low severe neutrophilic asthma. Journal of Allergy and Clinical Immunology. 2021.
    11. Villani A, Pavel AB*, Wu J, Fernandes M, Maari C, Saint-Cyr E, Jack C, Glickman J, Choi S, He H, Ungar B, Estrada Y, Kameyama N, Zhang N, Gonzales J, Tardif JC, Krueger J, Bissonnette R, Guttman-Yassky E. Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 response. Allergy. 2021. *shared first authorship.
    12. Renert-Yuval Y, Del Duca E, Pavel AB*, Wu J, Krueger JG, Paller A, Guttman-Yassky E et al., The molecular features of normal and atopic dermatitis skin in infants, children, adolescents and adults. Journal of Allergy and Clinical  Immunology. 2021. *shared first authorship.
    13. Glickman J, Dubin C, Dehabreh D, Han J, Del Duca E, Estrada Y, Zhang N, Kimmel G, Singer G, Krueger J, Pavel AB*, Guttman-Yassky E*, An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata. Allergy. 2021. *corresponding author.
    14. Dubin C, Glickman JW, Del Duca E, Chennareddy S, Han J, Dahabreh D, Estrada Y, Zhang N, Chowdhury M, Zheng A, Angelov M, Krueger JG, Pavel AB*, Guttman-Yassky E*. Skin and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement. Journal of American Academy of Dermatology. 2021. * corresponding author.
    15. Guttman-Yassky ERenert-Yuval YBares JChima MHawkes JGilleaudeau PSullivan-Whalen MSinger GKGarcet SPavel ABLebwohl MKrueger JG. Phase 2a randomized clinical trial of Dupilumab (anti-IL-4Ra) for alopecia areata patients. Allergy. 2021.
    16. Piscitelli S, Pavel AB, McHale K, Jett J, Collins J, Gillmor D, Tabolt G, Li R, Song T, Zhang N, Tallman A, Guttman-Yassky E.  A Phase 1b Randomized Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis. Journal of Investigative Dermatology. 2021.
    17. Czarnowicki T, Kim H, Villani A, Glickman J, Del Duca E, Han J, Pavel AB, Lee B, Rahman A, Merad M, Krueger J, Guttman E. High dimensional analysis defines multicytokine T-cell subsets and supports a role for IL-21 in atopic dermatitis. Allergy. 2021.
    18. Kim HJ, Singer GK, Del Duca E, Abittan BJ, Chima MA, Kimmel G, Bares J, Gagliotti M, Genece J, Chu J, Wilding G, Pavel AB, Guttman-Yassky E, Lebwohl MG. Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot study. Journal of American Academy of Dermatology. 2021.
    19. Pavel AB, Wu J, Renert-Yuval Y, Del Duca E, Glickman JW, Miller R, Paller A, Krueger JG, Guttman-Yassky E et al. SARS-CoV-2  receptor ACE2 protein expression in serum is significantly associated with age. Allergy. 2020 Jul  29.
    20. Glickman JW, Pavel AB, Guttman-Yassky E, Miller R. The role of  circulating eosinophilia on COVID-19 mortality varies by race/ethnicity. 2020. Allergy.
    21. Pavel AB, Renert-Yuval Y, Wu J, Del Duca E, Diaz A, Lefferdink R, Fang MM, Canter  T, Rangel SM, Zhang N, Krueger JG, Paller AS, Guttman-Yassky E. Tape-strips from early onset pediatric atopic dermatitis highlight disease abnormalities in non-lesional skin. Allergy.  2020 Jul 8.
    22. King B, Guttman-Yassky, Peeva E, Banerjee A, Sinclair R, Pavel AB, Zhu L, Cox LA, Craiglow B, Chen L, Banfield C, Page K, Zhang W, Vincent M. A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results. Journal of the American Academy of Dermatology. 2021.
    23. Ungar B, Pavel AB, Robson PM, Kaufman A, Pruzan A, Brunner P, Kaushik S, Krueger JG, Lebwohl MG, Mani V, Fayad ZA, Guttman-Yassky E. A Preliminary 18F-FDG-PET/MRI Study Shows Increased Vascular Inflammation in Moderate-to-Severe Atopic Dermatitis. J Allergy Clin Immunol Pract. 2020 Jul 25:S2213-2198(20)30726-1. doi: 10.1016/j.jaip.2020.07.018.
    24. Meyer Olesen C, Pavel AB*, Wu J, Mikhaylov D, Del  Duca E, Estrada Y, Krueger JG, Zhang N, Clausen ML, Agner T, Guttman-Yassky E. Tape-strips provide a minimally-invasive approach to track therapeutic  response to topical corticosteroids in atopic dermatitis patients. J Allergy Clin Immunol Pract.  2020 Sep 1;S2213-2198(20)30869-2. doi: 10.1016/j.jaip.2020.08.037. *shared first authorship.
    25. He H, Olesen CM, Pavel AB*, Clausen ML, Wu J, Estrada Y, Zhang N, Agner T,  Guttman-Yassky E. Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab  Identifies Minimally Invasive Biomarkers. Front Immunol. 2020 Aug 6;11:1768. doi:  10.3389/fimmu.2020.01768. eCollection 2020. *shared first authorship.
    26. Glickman JW, Han J, Garcet S, Krueger JG, Pavel AB, Guttman-Yassky E. Improving  evaluation of drugs in atopic dermatitis by combining clinical and molecular measures. Journal  of Allergy and Clinical Immunology In Practice. 2020 Jul 20;S2213-2198(20)30723-6.
    27. He H, Bissonnette R, Wu J, Diaz A, Saint-Cyr Proulx E, Maari C, Jack C, Louis M,  Estrada Y, Krueger JG, Zhang N, Pavel AB, Guttman-Yassky E. Tape strips detect distinct  immune and barrier profiles in atopic dermatitis and psoriasis. Journal of Allergy and Clinical  Immunology. 2020 Jul 9;S0091-6749(20)30824-1. 6749(20)30824-1/pdf
    28. Glickman JW, Dubin C, Han J, Dahabreh D, Garcet S, Krueger JG, Pavel AB*,  Guttman-Yassky E*. Comparing cutaneous molecular improvement with different treatments in  atopic dermatitis patients. Journal of Allergy and Clinical Immunology.  Volume 145, Issue 4, Pages 1285–1288. 2020. *corresponding author.
    29. Schipani G, Del Duca E, Todaro G, Scali E, Dastoli S, Bernardo L, Bonacci S, Di Raimondo C, Pavel AB, Colica C, Xu X, Procopio A, Patruno C, Nistico S. Arsenic and chromium levels in hair correlate with actinic keratosis/non melanoma skin cancer: results of an observational controlled study. G Ital Dermatol Venereol. 2020 Sept 17.
    30. Del Duca E, Ruano Ruiz J, Pavel AB et al. Frontal Fibrosing Alopecia shows robust Th1 and JAK3 skewing. Br J Dermatol. Br J Dermatol. 2020 Mar 25. doi: 10.1111/bjd.19040
    31. Ungar B, Pavel AB, Li R, Phase 2 Randomized, Double-blind Study of IL-17-Targeting with Secukinumab in Atopic Dermatitis. Journal of Allergy and Clinical Immunology.  2020 May 16;S0091-6749(20)30684-9. *shared first authorship.
    32. Glickman J, Dubin C, Renert-Yuval Y, Dahabreh D, Kimmel G, Auyeung K, Estrada  Y, Singer G, Krueger J, Pavel AB, Guttman-Yassky E. Cross-sectional study of blood biomarkers of patients with moderate-to-severe alopecia areata reveals systemic  immune and cardiovascular biomarker dysregulation. J Am Acad Dermatol. 2020 May 4;S0190- 9622(20)30759-3.
    33. Guttman E, Gallo R, Pavel AB, et al., A Nitric Oxide-releasing Topical Medication as a  New Potential Treatment Option for Atopic Dermatitis Through Antimicrobial and Anti inflammatory Activity. J Invest Dermatol. 2020 May 16;S0022-202X(20)31571-2.
    34. He H, Del Duca E, Diaz A, Kim HJ, Gay-Mimbrera J, Zhang N, Wu J, Beaziz J, Estrada Y, Krueger JG, Pavel AB, Ruano J, Guttman-Yassky E. Mild atopic dermatitis lacks systemic inflammation, and shows reduced non-lesional skin abnormalities. Journal of Allergy and Clinical Immunology. 2020.
    35. Wu J, Del Duca E, Espino M, Gontzes A, Cueto I, Zhang N, Estrada Y, Pavel AB, Krueger JG, Guttman-Yassky E. RNA sequencing keloid transcriptome associates keloids with Th2, Th1, Th17/Th22 and JAK3-skewing. Frontiers in Immunology. 2020.
    36. Morelli P, Gaspari M, Gabriele C, Dastoli S, Bernnardo L, Pavel AB, Patrono C, Del Duca E, Nistico S. Proteomic analysis from skin swabs reveals a new set of proteins identifying skin impairment in Atopic Dermatitis. Experimental Dermatology. 2021.
    37. Mikhaylov D, Del Duca E, Meyer C, He H, Wu J, Ungar B, Estrada Y, Zhang N, Chowdhury M, Clausen M, Krueger JG, Pavel AB, Agner T, Guttman-Yassky E. Transcriptomic profiling of tape-strips from moderate-to-severe atopic dermatitis patients treated with dupilumab. Dermatitis. 2021. In Press.
    38. Lang C, Renert-Yuval Y, Del Duca E, Pavel AB, Wu J, Guttman-Yassky E et al. Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients. Annals of Allergy, Asthma & Immunology. 2021. In Press.
    39. Pavel AB, Song T, Kim H.J. et al. Oral JAK/SYK-inhibition (ASN002)  suppresses inflammation and improves epidermal barrier in atopic dermatitis. Journal of Allergy and Clinical Immunology. Volume 144, Issue 4, October 2019, Pages 1011-1024.2019.
    40. Pavel AB, Zhou L, Diaz A, Ungar B et al., The proteomic skin profile of moderate-to severe atopic dermatitis patients shows an inflammatory signature. Journal of American  Academy of Dermatology. 2019.
    41. Fleck J, Pavel AB*, Cassandras G. A pan-cancer analysis of progression mechanisms  and drug sensitivity in cancer cell lines. Mol Omics. 2019. *shared first authorship.
    42. Bissonnette R, Pavel AB, Diaz Aisleen et al. Crisaborole and atopic dermatitis skin  biomarkers: an intrapatient randomized trial. Journal of Allergy and Clinical Immunology. 2019.
    43. Brunner PM, Pavel AB*, Saakshi Khattri et al. Baseline IL-22 expression in atopic  dermatitis patients stratifies therapeutic responses to Fezakinumab. * Equal Contribution. Journal of Allergy and Clinical Immunology. 2019. 143(1):142-154. *shared first authorship.
    44. Guttman-Yassky E., Diaz Aisleen, Pavel AB et al. Immune and barrier abnormalities in  early onset atopic dermatitis are captured by tape strips. JAMA Dermatology. 2019.
    45. Diaz A, Tan K, He H, Xu H, Cueto I, Pavel AB, Krueger JG, Guttman-Yassky E. Keloid  lesions show increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy. J  Eur Acad Dermatol Venereol. 2019.
    46. Guttman-Yassky E, Pavel AB, Zhou L. et al. GBR 830, an anti-OX40, improves skin  gene signatures and clinical scores in patients with atopic dermatitis. Journal of Allergy and  Clinical Immunology. 2019. 144(2): 482–493.
    47. Bissonnette R, Maari C, Forman S, Bhatia N, Lee M, Fowler J, Tyring S, Pariser D,  Sofen H, Dhawan S, Zook M, Zammit D.J., Usansky H, Denis L, Rao N, Song T, Pavel AB,  Guttman-Yassky E. The Oral JAK/SYK Inhibitor ASN002 Demonstrates Efficacy and Improves  Associated Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis:  Results from a Randomised, Double-Blind, Placebo-Controlled Study. Br J Dermatol. 2019.
    48. Sanyal R.D., Pavel AB, Krueger J.G., Guttman-Yassky E., et al., Atopic dermatitis in  African American patients is TH2/TH22-skewed with Th1/Th17 attenuation. Ann Allergy  Asthma Immunol. 2019. 122(1):99-110.e6. doi: 10.1016/j.anai.2018.08.024.
    49. Zhou L, Leonard A, Pavel AB et al. Age-specific changes in the molecular phenotype of  patients with moderate-to-severe atopic dermatitis. Journal of Allergy and Clinical Immunology.  2019. 144(1): 144–156.
    50. Mikhaylov D, Pavel A et al. A randomized placebo-controlled single-center pilot study  of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata.  Arch Dermatol Res. 2019. 311(1):29-36. 1876-y
    51. Brunner P.M., Israel A, Leonard A, Pavel AB et al. Distinct transcriptomic profiles of  early-onset atopic dermatitis in blood and skin of pediatric patients. Ann Allergy Asthma  Immunol. 2019. 122(3):318-330.e3.
    52. Del Duca E, Pavel AB et al. Major differences in expression of inflammatory pathways  in skin from different body sites of healthy individuals. Journal of Investigative Dermatology.  2019.
    53. Brunner P.M., He H, Pavel AB et al. The blood proteomic signature of early-onset  pediatric atopic dermatitis shows systemic inflammation and is distinct from adult, long standing  disease. Journal of American Academy of Dermatology. 2019; 2(81):510–519
    54. Czarnowicki T, He H, Canter T, Han J, Lefferdink R, Erickson T, Rangel S, Kameyama  N, Kim H, Pavel AB, Estrada Y, Krueger, J.G., Paller A, Guttma-Yassky G. Evolution of  pathologic T-cell subsets in atopic dermatitis from infancy to adulthood. Journal of Allergy and  Clinical Immunology. 2019.
    55. He H, Li R, Choi S, Zhou L, Pavel A, Estrada YD, Krueger JG, Guttman-Yassky E. Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic  dermatitis. Ann Allergy Asthma Immunol. 2019. 1206(19)31294-3/fulltext
    56. Min M, Wu J, He H, Cabanillas JL, Zhang N, Pavel AB, Lebwohl M, Guttman-Yassky  E. Granuloma annulare skin profile shows profound activation of Th1, Th2, and JAK pathways.  Journal of American Academy of Dermatology. 2019. 9622(19)33305-5/pdf
    57. Guo CJ, Mack MR, Oetjen LK, Council ML, Pavel AB, Guttman-Yassky E, Kim BS,  Liu Q. Kallikrein 7 promotes atopic dermatitis-associated itch independently of skin  inflammation. J Invest Dermatol. 2019.
    58. Song T, Pavel AB, Wen H.C., Malik K., Estrada Y., Gonzalez J., Hashim P., Nia J.,  Baum D., Kimmel G., Singer G., Krueger J.G., Guttman-Yassky E., An Integrated model of  Alopecia Areata biomarkers highlights both Th1/Th2 up-regulation. Journal of Allergy and  Clinical Immunology. 2018. 142(5):1631–1634.
    59. Guttman-Yassky E., Brunner P., Neumann A., Khattri S., Pavel AB, Krueger J.G,  Lebwohl M. et al., Fezakinumab (anti-IL-22) in moderate-to-severe atopic dermatitis patients. J  Am Acad Dermatol. 2018. 78(5):872-881.
    60. Chan T.C., Sanyal R.D., Pavel AB, Glickman J., Zheng X., Xu H., Cho Y.T., Tsai T.F.,  Wen H.C., Peng X., Cueto I., Krueger J.G., Guttman-Yassky E. Atopic dermatitis in Chinese  patients shows TH2/TH17-skewing with psoriasiform feature. Journal of Allergy and Clinical  Immunology. 2018. 142(3):1013–1017.
    61. Wen H.C, Czarnowicki T., Noda S., Malik K., Pavel AB, Guttman-Yassky E. et al.,  Asian atopic dermatitis serum is characterized by elevated Th2/Th22, but low Th1 signatures,  and is highly correlated with non-lesional skin measures. Journal of Allergy and Clinical  Immunology. 2018 Jul;142(1):324-328.e11.
    62. Simpson EL, Imafuku S, Poulin Y, Ungar B, Zhou L, Malik K, Wen HC, Xu H, Estrada  YD, Peng X, Chen M, Shah N, Suarez-Farinas M, Pavel AB, Nograles K, Guttman-Yassky E.  A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis. Journal of  Investigative Dermatology. 2018. 138(5):1063–1072.
    63. Czarnowicki T, He H, Leonard A, Kim H, Kameyama N, Pavel AB et al. Blood  endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune  skin diseases. Journal of Allergy and Clinical Immunology. 2018. 143(6): 2095–2107.
    64. Pavel AB, Korolev S.K. Genetic load makes cancer cells more sensitive to common  drugs: evidence from Cancer Cell Line Encyclopedia. Scientific Reports. 2017. 7(1938). Springer Nature. DOI:10.1038/s41598-017-02178-1
    65. Pavel AB, Joshua Campbell, Marc Lenburg, Avrum Spira et al. microRNA Expression  in Bronchial Epithelium for Lung Cancer Detection. Cancer Prevention Research (AACR  Journal). 2017. 10(11):651-659. DOI:10.1158/1940-6207.CAPR-17-0098. 0098
    66. Pavel AB, Sonkin D., Reddy A. Integrative modeling of multi-omics data to identify  cancer drivers and infer patient-specific gene activity. BMC Systems Biology. 2016. 10(16).  Open Access.
    67. Fleck J.L., Pavel AB*, Christos C.G. Integrating mutation and gene expression cross-sectional data to infer cancer progression, BMC Systems Biology.  2016. 10(12). Open Access. *corresponding author.
    68. Pavel AB and Vasile C.I. Identifying cancer type specific oncogenes and tumor  suppressor genes in limited size data. Journal of Bioinformatics and Computational Biology.  2016. 14(6). Open Access.
    69. Pavel AB, Dumitrache D. Hybrid Numerical P Systems, UPB Scientific Bulletin. Series  A: Applied Mathematics and Physics. 2016. 78(2):139-146.
    70. Vasile C.I., Pavel AB , Dumitrache I. Universality of Enzymatic Numerical P Systems. International Journal of Computer Mathematics. 2013. 90(4):869-879. 
    71. Vasile C.I., Pavel AB, Dumitrache I., Paun Gh. Numerical P Systems, chapter in  Gheorghe M., Paun G., Perez-Jiminez M., Rozenberg G., Research Frontiers of Membrane  Computing: Open Problems and Research Topics, International Journal of Foundations of  Computer Science. Vol.24. No.5. 2013.
    72. Pavel AB, Vasile C.I. PyElph – a Software Tool for Gel Images Analysis and  Phylogenetics, BMC Bioinformatics. 2012. 13(9). Open Access (Highly Accessed)
    73. Vasile C.I., Pavel AB, Dumitrache I, Paun Gh. On the Power of Enzymatic Numerical P  Systems, Acta Informatica, Springer. 2012. 49(6):395-412. DOI:10.1007/s00236-012-0166-y.
    74. Pavel AB and Buiu C. Using enzymatic numerical P systems for modeling mobile robot  controller. Natural Computing. 2012. Springer, 11(3):387-393. 011-9286-5
    75. Pavel AB and Buiu C. Development of an embedded artificial vision system for an  autonomous robot. International Journal of Innovative Computing, Information and Control. 2011. 7(2):745-762. ISSN 1349-4198.
    76. Mu X., Pavel AB, Kon M., Differentiation and Integration of Machine Learning  Feature Vectors, Proceedings of 2016 15th IEEE International Conference on Machine Learning  and Applications (ICMLA), Anaheim, CA, USA.
    77. Pavel AB, Vasile C.I., Dumitrache I. Robot localization implemented with enzymatic  numerical P systems, Living Machines 2012 – The International Conference on Biomimetic and  Biohybrid Systems, Barcelona, Spain, July 9-12, 2012, Proceedings in Lecture Notes in Artificial Intelligence (ISI Conference Proceedings), 7375:204-215. Springer. 2012.
    78. Vasile C.I., Pavel AB, Dumitrache I. Improving the universality results of Enzymatic  Numerical P Systems, Proceedings of 10th Brainstorming Week on Membrane Computing,  2:207-214, Seville, Spain, January 30-February 3. 2012. 
    79. Vasile C.I., Pavel AB, Dumitrache I., Kelemen J. Implementing obstacle avoidance and  follower behaviors on Koala robots using Numerical P Systems, Proceedings of the 10th  Brainstorming Week on Membrane Computing, vol. 2:215-228, Seville, Spain, January 30 – February 3, 2012
    80. García-Quismondo M., Pavel AB, Pérez-Jiménez. M.J. Simulating Large-Scale ENPS  Models by Means of GPU, Proceedings of the 10th Brainstorming Week on Membrane  Computing, 1:137-152, Seville, Spain, January 30-February 3. 2012. 
    81. Vasile C.I., Pavel AB , Dumitrache I., Paun Gh., Numerical P Systems, section in the  collective paper Research Topics in Membrane Computing: After CMC 12, Before BWMC 10,  Eds. Gheorghe M., Paun Gh., Perez-Jimenez M.J., 10th Brainstorming Week on Membrane  Computing, Seville, Spain, January 30-February 3, 2012  
    82. Vasile C.I., Pavel AB, Buiu C., Integrating human swarm interaction in a distributed  robotic control system, Proceedings of IEEE 7th Annual IEEE Conference on Automation  Science and Engineering (CASE 2011), Trieste, pp. 743 – 748, Italy, 24-27 August. 2011.
    83. Buiu C., Pavel AB, Vasile C.I., Dumitrache I. Perspectives of using membrane  computing in the control of mobile robots, Proceedings of Beyond AI: Interdisciplinary Aspects  of Artificial Intelligence (BAI 2011), pp. 21-26, Pilsen, Czech Republic, December 8-9.  2011.
    84. Pavel AB, Arsene O., Buiu C. Enzymatic Numerical P Systems –A New Class of  Membrane Computing Systems, Proceedings of BIC-TA 2010, Proceedings of IEEE Fifth International Conference on Bio-Inspired Computing: Theory and Applications, 2:1331-1336,  Liverpool, U.K., doi:10.1109/BICTA.2010.5645071. 2010.
    85. Vasile C.I., Pavel AB, Buiu C. Chidori – a bio-inspired cognitive architecture for  collective robotics applications, Proceedings of WICS, 8(1):52-57, IFAC Workshop on  Intelligent Control Systems, Sinaia, Romania, October. 2010. http://www.ifac
    86. Pavel AB, Vasile C, Buiu C. Cognitive vision system for an ecological mobile robot,  Proceedings of SINTES 13, The International Symposium on System Theory, Automation,  Robotics, Computers, Informatics, Electronics and Instrumentation, 1:267-272, Craiova,  Romania, October 2007 

    Books and Book Chapters 

    1. Pavel AB, Vasile CI, Dumitrache I. Membrane computing in robotics, book chapter in  special issue Kelemen J., Romportl J., Zackova E. (Eds.), Beyond Artificial Intelligence:  Contemplations, Expectations, Applications (Topics in Intelligent Engineering and Informatics),  Springer, 2012 Expectations/dp/3642344216 
    2. Pavel AB, Vasile CI, Buiu C. Biomathematics and Bioinformatics. Concepts and  Applications (in Romanian), p. 222, Ed. Universitară, ISBN 978-606-591-178-9, 2011 
    3. Buiu C, Pavel AB, Vasile C. Cognitive Robots. Bio-inspired applications (in  Romanian), p. 188, Ed. Universitară, Bucharest, ISBN 978-973-749-835-9 (online ISBN 978- 973-749-873-1), 2010 
    4. Pavel AB and Vasile CI. Robots with cognitive vision. Case study Remaster One robot,  chapter in Buiu C. (Ed.), Cognitive robotics Concepts, architectures, applications (in  Romanian), pp. 35-97. Ed. Universitară, Bucharest, ISBN 978-973-749-443-6, 2008